SANUWAVE Health, Inc. (OTCMKTS:SNWV) – Zacks Investment Research reduced their FY2018 earnings per share estimates for SANUWAVE Health in a research note issued on Monday, December 3rd. Zacks Investment Research analyst B. Marckx now expects that the company will post earnings per share of ($0.09) for the year, down from their prior forecast of ($0.08). Zacks Investment Research also issued estimates for SANUWAVE Health’s Q4 2018 earnings at ($0.02) EPS.
Shares of OTCMKTS SNWV opened at $0.29 on Thursday. SANUWAVE Health has a 1-year low of $0.10 and a 1-year high of $0.64. The stock has a market cap of $38.88 million, a price-to-earnings ratio of -7.18 and a beta of -2.15.
SANUWAVE Health (OTCMKTS:SNWV) last posted its quarterly earnings data on Tuesday, November 20th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.01. The firm had revenue of $0.60 million during the quarter, compared to analysts’ expectations of $0.68 million.
About SANUWAVE Health
SANUWAVE Health, Inc, a shock wave technology company, focuses on the development and commercialization of noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications worldwide. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.
Further Reading: How Do I Invest in Dividend Stocks
Receive News & Ratings for SANUWAVE Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SANUWAVE Health and related companies with MarketBeat.com's FREE daily email newsletter.